No photo of Hsingjin-Eugene Liu

View Scopus Profile

Hsingjin-Eugene Liu

Visiting staff

  • 1077 Citations
  • 17 h-Index
19952018

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hsingjin-Eugene Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Identification of Roles of microRNAs in Drug Resistance Development of Chronic Myeloid Leukemia

Shih, C. & Liu, H.

8/1/15 → 7/31/16

Project: A - Government Institution › b - Ministry of Science and Technology

Developing New Diagnostic and Therapeutic Strategies for Lung Cancer with ROS1, RET and NTRK1 Mutations in Patients without EGFR, KRAS and ALK Mutations

Liu, H.

8/1/14 → 7/31/15

Project: A - Government Institution › b - Ministry of Science and Technology

Using chemical synthetic lethal screening to identify novel compounds that sensitize acute myeloid leukemia with FLT3-ITD mutations to novel small-molecule FLT3 tyrosine kinase inhibitors, ITRI-260 and overcome microenvironment-mediated drug resistan

Liu, H.

8/1/13 → 7/31/14

Project: A - Government Institution › b - Ministry of Science and Technology

Study on the Immuno-Modulatory Effects of Notch Ligand Delta 4 on Immune Cells and in Ova-Induced Asthmatic Mice

Lee, Y., Leu, S. & Liu, H.

8/1/11 → 7/31/12

Project: A - Government Institution › b - Ministry of Science and Technology

Research Output

  • 1077 Citations
  • 17 h-Index
  • 43 Article

Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma

Wang, J. L., Fang, C. L., Tzeng, Y. T., Hsu, H. L., Lin, S. E., Yu, M. C., Bai, K. J., Wang, L. S. & Liu, H. E., Jun 28 2018, In : Journal of Biomedical Science. 25, 1, 53.

Research output: Contribution to journal › Article

    • 1 Citation (Scopus)

    Brain metastases in patients with non-small cell lung cancer: the role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination

    Hsiao, S-H., Chou, Y-T., Lin, S-E., Hsu, R-C., Chung, C-L., Kao, Y-R., Liu, H. E. & Wu, C-W., Aug 8 2017, In : Oncotarget. 8, 32, p. 53405-53418 14 p.

    Research output: Contribution to journal › Article

    • MicroRNA-1301-mediated RanGAP1 downregulation induces BCR-ABL nuclear entrapment to enhance imatinib efficacy in chronic myeloid leukemia cells

    Lin, T. Y., Chen, K. C., Liu, H. J. E., Liu, A. J., Wang, K. L. & Shih, C. M., May 1 2016, In : PLoS One. 11, 5, e0156260.

    Research output: Contribution to journal › Article

    • 7 Citations (Scopus)

    MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation

    Wang, C. C., Liu, H. E., Lee, Y. L., Huang, Y. W., Chen, Y. J., Liou, J. P. & Huang, H. M., May 1 2016, In : Tumor Biology. 37, 5, p. 6065-6072 8 p.

    Research output: Contribution to journal › Article

    • 5 Citations (Scopus)

    Establishment of a cost-effective method to detect FLT-ITD and D835 mutations in acute myeloid leukemia patients in the Taiwanese population

    Liu, H. E., Ko, C. H., Lam, F., Wu, L. S. H. & Lee, K. F., Mar 1 2015, In : Tzu Chi Medical Journal. 27, 1, p. 18-24 7 p.

    Research output: Contribution to journal › Article

    • 2 Citations (Scopus)